Aptar Pharma Launches First Metal-Free Nasal-Spray Pump, Meets Growing Need for Highly Recyclable Packaging
By Aptar Radolfzell GmbH
APF Futurity nasal-spray pump certified ‘highly recyclable’ by cyclos-HTP
Crystal Lake, IL, Jan. 30, 2023 — Aptar Pharma, part of AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery systems, services and active material-science solutions, today announces the launch of APF Futurity, its first metal-free, multidose nasal-spray pump developed to deliver nasal saline and other comparable over-the-counter (OTC) formulations.
Specifically designed for recyclability, APF Futurity is Aptar Pharma’s first highly recyclable nasal-spray pump, having achieved a Class AA certification from cyclos-HTP for recycling streams in Europe. APF Futurity is made from polyolefin materials with no metal parts or recycling disruptors, thereby minimizing separation efforts in recycling streams and supporting a higher quality of recyclates.
Gael Touya, President of Aptar Pharma, commented, “As a leading provider of nasal spray pumps globally, the launch of APF Futurity is a significant step forward in our sustainability journey, underlining Aptar’s overall commitment to a more circular economy and meeting the global need for sustainable packaging solutions that are easy to recycle.”
Part of Aptar Pharma’s Futurity sustainable solutions platform, APF Futurity meets a growing consumer need for increased access to recyclable products. In a study conducted by Aptar Pharma in 2022, 77 per cent of respondents indicated that it was ‘important’ or ‘very important’ that the products they buy can be recycled.
When used in combination with a high-density polyethylene (HDPE) or polypropylene (PP) container bottle, a product with the APF Futurity pump can be conveniently recycled as one piece when empty after use, with no need to separate or detach any parts or materials before disposal, a key user benefit.
Innovative design based on proven technology
APF Futurity is based on Aptar Pharma’s proven Advanced Preservative Free (APF) technology platform, and has been initially developed to deliver multidose nasal saline and comparable OTC formulations. The innovative metal-free pump, for which patent protection has been filed, delivers precise and consistent dosing with soft actuation, with no trade-off on handling and performance.
“APF Futurity is a game-changing innovation for the nasal-spray-pump industry, and I am proud of our design and engineering team for meeting the challenge of designing this metal-free nasal pump,” stated Stefan Ritsche, President of Global Market Development in Consumer Health Care with Aptar Pharma. “This is an important step in the transformation of our nasal spray portfolio to more sustainable solutions, and we look forward to bringing additional innovations of this kind to meet the need in the pharmaceutical industry.”
Aptar’s commitment to sustainability
Driven by our commitment to sustainable practices and products, with a focus on delivering transformative solutions that improve our world, Aptar continues to shape the drug delivery and consumer product dispensing markets.
“Aptar continues to receive recognition for our sustainable product innovations, including the Institute of Packaging Professionals (IOPP) and WorldStar Global Packaging awards, and we were recently ranked #15 on Newsweek’s ‘America’s Most Responsible Companies’ list,” added Christophe Marie, Product Sustainability Director for Aptar. “Aptar Pharma’s launch of APF Futurity is yet another sustainable product innovation that reinforces our pledge to care for our planet and reduce our environmental impact.”
Aptar Pharma will unveil the APF Futurity pump at Pharmapack 2023, which takes place Feb. 1-2, 2023 in Paris, France. Visit the APF Futurity product page for more information.
About Aptar Pharma
Aptar Pharma is part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home care, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
Advertisement
